Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-02
1997-08-26
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548200, 548518, A61K 31425, C07D41714
Patent
active
056611676
ABSTRACT:
The present invention relates to compounds of formula 1, ##STR1## including all of its stereoisomers, compositions, and processes for preparation of the same. The compounds of the present invention are also useful in their pharmacological activities as they directly act as inhibitors of prolyl endopeptidase and thereby provide a methods for memory enhancement, preventing or slowing the affects of amnesia or memory deficits.
REFERENCES:
patent: 4518528 (1985-05-01), Rasnick et al.
patent: 4855303 (1989-08-01), Hoover et al.
patent: 4912127 (1990-03-01), Henning
Yoshimoto, et al., Agric. Biol. Chem. 55(1), 37-43, 1991.
Saito, et al., J. Enzyme Inhibition, 1991, vol. 5, pp. 51-75.
CA Selects: Amino Acids, Peptides, & Proteins, Issue 16, 1991, 115:50303q abstracting Uchida, et al., PCT Int. Appl. WO 90 12,005 18 Oct. 1990.
CA Selects: Amino Acids, Peptides, & Proteins, Issue 9, 1991, 114: 164802m abstracting Shioiri, et al., EP Appl. 384,341, 29 Aug. 1990.
Atack, et al., European Journal of Pharmacology, 205 (1991) 157-163.
Wilk, et al., Journal of Neurochemistry, vol. 41, No. 1, 69-75, 1983.
Friedman, et al., Journal of Neurochemistry, vol. 42, No. 1, 237-241, 1984.
Nishikata, et al., Chem. Pharm. Bull. 34(7) 2931-2936 (1986).
Yoshimoto, et al., Agric. Biol. Chem., 55(1), 37-43, 1991.
CA Selects: Amino Acids, Peptides, & Proteins, Issue 24, 1991, 115:232893q abstracting Furukawa, et al., JP 03 56,460, 12 Mar. 1991.
CA Selects: Amino Acids, Peptides, & Proteins, Issue 24, 1991, 115:232874j abstracting Furukawa, et al., JP 03 56,461, 12 Mar. 1991.
Bakker, et al., Bioorganic & Medicinal Chemistry Letters, vol. 1, No. 11, pp. 585-590, 1991.
Tsuru, et al., J. Biochem. 104, 580-586 (1988). J. Burkhart to KJC Mar. 20, 1992.
Yoshimoto, et al., Biochemistry, vol. 16, No. 13, pp. 2942-2948, 1977.
Angelastro, et al., Tetrahedron Letters, vol. 33, No. 23, pp. 3265-3268, 1992.
Sham, H.L. et al., FEBS Letters, vol. 220, No. 2, pp. 299-301 (1989).
Powers, J.C., Eleventh American Peptide Symposium, Abstracts, The Salk Institute and University of CA, San Diego (1989).
Imperiali, B., et al., Biochemistry, vol. 25, 3760-3767 (1986).
Stein, R.L., et al., Biochemistry 26, 2682-2689 (1987).
Chemical Abstracts 110:76058k, vol. 110 (1989), abstracting Angliker, H., et al., Biochem. J. 256(2), 481-6, 1988.
Chemical Abstracts 106:850589f, vol.106 (1987), abstracting JP 86, 183,253, Aug. 15, 1986.
Ueda, T. et al., Biochem. J. 265, 539-545 (1990).
Synthesis, 676-678 (1983). Internal report.
Gassman, P.G., et al., J. Org. Chem. 52, 2481-2490 (1987). Internal report.
Tsuru, et al., J. Biochem., 104, 580-586 (1988).
Burkhart Joseph P.
Mehdi Shujaath
Peet Norton P.
Collier Kenneth J.
Gerstl Robert
Merrell Pharmaceuticals Inc.
LandOfFree
Prolyl endopeptidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolyl endopeptidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolyl endopeptidase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988811